Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

RDInvesting Provides Investors with Free In-Depth Equity Reports on APD, CAH, DGX and VMW

APD, CAH, DGX

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.

Air Products & Chemicals, Inc. (NYSE: APD) shares increased 0.59 percent to close at $110.02 a share Thursday. The stock traded between $109.47 and $111.40 on volume of 1.11 million shares traded. Analysts at Atlantic Equities have recently upgraded the company’s rating to "overweight" from "neutral". Shares of Air Products & Chemicals have gained approximately 30.0 percent year-to-date.

Find out more about Air Products & Chemicals including full access to the free equity report at:
www.RDInvesting.com/APD

Cardinal Health Inc. (NYSE: CAH) shares increased 0.24 percent to close at $53.45 a share Thursday. The stock traded between $53.15 and $53.92 on volume of 2.34 million shares traded. Analysts at Sterne Agee have recently initiated coverage on the company with a "neutral" rating and a price target of $48.00. Shares of Cardinal Health have gained approximately 30.0 percent year-to-date.

Find out more about Cardinal Health including full access to the free equity report at:
www.RDInvesting.com/CAH

Quest Diagnostics Inc. (NYSE: DGX) shares declined 0.31 percent to close at $61.81 a share Thursday. The stock traded between $61.73 and $62.71 on volume of 1.95 million shares traded. Analysts at Craig-Hallum have recently initiated coverage on the company with a "buy" rating and a price target of $74.00. Shares of Quest Diagnostics have gained approximately 6.0 percent year-to-date.

Find out more about Quest Diagnostics including full access to the free equity report at:
www.RDInvesting.com/DGX

VMware, Inc. (NYSE: VMW) shares declined 0.30 percent to close at $88.89 a share Thursday. The stock traded between $88.67 and $90.60 on volume of 1.24 million shares traded. Analysts at Janney Capital have recently initiated coverage on the company with a "buy" rating and a price target of $100.00. Shares of VMware have fallen approximately 5.5 percent year-to-date.

Find out more about VMware including full access to the free equity report at:
www.RDInvesting.com/VMW

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com